Fink, Thomas http://orcid.org/0000-0002-6665-7326
Metzner, Andreas
Willems, Stephan
Eckardt, Lars
Ince, Hüseyin
Brachmann, Johannes
Spitzer, Stefan G.
Deneke, Thomas
Schmitt, Claus
Hochadel, Matthias
Senges, Jochen
Rillig, Andreas
Funding for this research was provided by:
Stiftung Institut für Herzinfarktforschung
Article History
Received: 1 December 2018
Accepted: 25 March 2019
First Online: 5 April 2019
Compliance with ethical standards
:
: Dr. Metzner received speaker’s honoraria from Medtronic. Dr. Willems received speaker honoraria from Abott, Boston Scientific, Boehringer Ingelheim, Bristol Myers Squibb, Bayer Vital, Acutus and study funding from Abott, Boston Scientific and Acutus. Dr Eckardt consulting fees/speaker honoraria from Bayer Health Care, Daiichi Sankyo, Pfizer, Bristol-Myers, Squibb, Boehringer Ingelheim, Johnson&Johnson, Medtronic, Boston Scientific, Abbott, Novartis and research support by the DFG the German Heart Foundation. Dr Brachmann received consulting fees/honoraria from Biotronik, Biosense Webster, Medtronic, Boston Scientific, and St. Jude Medical. Dr Rillig received travel grants/lecture fees from Biosense, Hansen Medical, Medtronic, EP Solutions and St. Jude Medical and participated at the Boston scientific EP-fellowship. The other authors report no conflict of interest.